Official ESCRS | European Society of Cataract & Refractive Surgeons
London 2014 Registration Visa Letters Programme Satellite Meetings Glaucoma Day 2014 Exhibition Hotel Booking Virtual Exhibition Star Alliance
london escrs

Course handouts are now available
Click here


Come to London

video-icon

WATCH to find out why


Site updates:

Programme Updates. Programme Overview and - Video Symposium on Challenging Cases now available.


Posters

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Surgical management of the blockade intrascleral pathway after hypotensive operations: long-term results

Poster Details

First Author: I.Shiryaev RUSSIA

Co Author(s):    I. Baranov   L. Perevedentseva   I. Shiryaev        

Abstract Details



Purpose:

the goal of this report is to introduce a technique of transcorneal activation of the site of previous hypotensive surgery, it's complications and long-term results.

Setting:

Academician S.N.Fedorov St. Petersburg Branch of the IR&TC 'Eye microsurgery' St. Petersburg, Russia.

Methods:

the study enrolled 100 patients aged from 39 to 84 who underwent a transcorneal activation procedure due to decompensation of intraocular pressure 2 weeks - 20 years after previous hypotensive surgery. Group one included 40 patients after non-penetrating deep sclerectomy. Group 2 consisted of 60 patients after a penetrating hypotensive surgery.

Results:

There were no intraoperative complication during the transcorneal activation procedure in both groups. Postoperative complications occured in 5% of patients in group 1 (ciliochoroidal detachment) and in 8,3% of patients in group 2 (hyphemas and ciliochoroidal detachment). In both groups a statistically reliable decrease of intraocular pressure comparing to preoperative values was present during the whole period of follow-up (up to 3 years) and averaged 34,6%.

Conclusions:

transcorneal activation of the site of previous hypotensive surgery is the operation of choice, particularly in terms of up to 5 years and it's provides stable hypotensive effect. FINANCIAL INTEREST: NONE

Back to Poster listing